173 related articles for article (PubMed ID: 22985026)
1. Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR- and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases.
Dagur PK; Sharma B; Upadhyay R; Dua B; Rizvi A; Khan NA; Katoch VM; Sengupta U; Joshi B
Lipids Health Dis; 2012 Sep; 11():119. PubMed ID: 22985026
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.
Dagur PK; Sharma B; Kumar G; Khan NA; Katoch VM; Sengupta U; Joshi B
Mol Immunol; 2010 Feb; 47(5):943-52. PubMed ID: 20018378
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis secretory proteins downregulate T cell activation by interfering with proximal and downstream T cell signalling events.
Sharma B; Upadhyay R; Dua B; Khan NA; Katoch VM; Bajaj B; Joshi B
BMC Immunol; 2015 Nov; 16():67. PubMed ID: 26552486
[TBL] [Abstract][Full Text] [Related]
4. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
[TBL] [Abstract][Full Text] [Related]
5. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
6. TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.
Lehnert C; Weiswange M; Jeremias I; Bayer C; Grunert M; Debatin KM; Strauss G
J Immunol; 2014 Oct; 193(8):4021-31. PubMed ID: 25217163
[TBL] [Abstract][Full Text] [Related]
7. ZAP-70 and SLP-76 regulate protein kinase C-theta and NF-kappa B activation in response to engagement of CD3 and CD28.
Herndon TM; Shan XC; Tsokos GC; Wange RL
J Immunol; 2001 May; 166(9):5654-64. PubMed ID: 11313406
[TBL] [Abstract][Full Text] [Related]
8. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
Nolz JC; Fernandez-Zapico ME; Billadeau DD
J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
[TBL] [Abstract][Full Text] [Related]
9. Filamin A is required for T cell activation mediated by protein kinase C-theta.
Hayashi K; Altman A
J Immunol; 2006 Aug; 177(3):1721-8. PubMed ID: 16849481
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cbeta1, a major regulator of TCR-CD28-activated signal transduction leading to IL-2 gene transcription and secretion.
Dreikhausen UE; Gorf K; Resch K; Szamel M
Int Immunol; 2003 Sep; 15(9):1089-98. PubMed ID: 12917261
[TBL] [Abstract][Full Text] [Related]
11. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities.
Michel F; Attal-Bonnefoy G; Mangino G; Mise-Omata S; Acuto O
Immunity; 2001 Dec; 15(6):935-45. PubMed ID: 11754815
[TBL] [Abstract][Full Text] [Related]
12. CD28 affects the earliest signaling events generated by TCR engagement.
Tuosto L; Acuto O
Eur J Immunol; 1998 Jul; 28(7):2131-42. PubMed ID: 9692882
[TBL] [Abstract][Full Text] [Related]
13. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
Salojin KV; Zhang J; Delovitch TL
J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678
[TBL] [Abstract][Full Text] [Related]
14. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
15. Short-interfering RNA-mediated Lck knockdown results in augmented downstream T cell responses.
Methi T; Ngai J; Mahic M; Amarzguioui M; Vang T; Tasken K
J Immunol; 2005 Dec; 175(11):7398-406. PubMed ID: 16301647
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
[TBL] [Abstract][Full Text] [Related]
17. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
[TBL] [Abstract][Full Text] [Related]
18. Vav1 Regulates T-Cell Activation through a Feedback Mechanism and Crosstalk between the T-Cell Receptor and CD28.
Helou YA; Petrashen AP; Salomon AR
J Proteome Res; 2015 Jul; 14(7):2963-75. PubMed ID: 26043137
[TBL] [Abstract][Full Text] [Related]
19. CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy.
Doz-Deblauwe É; Carreras F; Arbues A; Remot A; Epardaud M; Malaga W; Mayau V; Prandi J; Astarie-Dequeker C; Guilhot C; Demangel C; Winter N
Front Immunol; 2019; 10():2913. PubMed ID: 31921172
[No Abstract] [Full Text] [Related]
20. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells.
Kim JE; White FM
J Immunol; 2006 Mar; 176(5):2833-43. PubMed ID: 16493040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
